Steven W Pipe (Steven Pipe)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 55

Top Topics

Venous Thromboembolism

Inferior Vena Cava

Clinical Practice

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

Journal of thrombosis and haemostasis : JTH

This page only lists publications with an associated author ORCID identifier.

Publications

Robbin Itzler, Tyler W Buckner, Frank W G Leebeek, Joel Miller, Michael Recht, Douglass Drelich, Paul E Monahan, Steven W Pipe
Effect of etranacogene dezaparvovec on quality of life for severe and moderately severe haemophilia B participants: Results from the phase III HOPE-B trial 2 years after gene therapy. Haemophilia : the official journal of the World Federation of Hemophilia 30 (3) (2024)
Suresh Agarwal, Cedric Hermans, Wolfgang A Miesbach, Flora Peyvandi, Robert F Sidonio, Dane Osmond, Vanessa Newman, Josh Henshaw, Steven W Pipe
Transitioning from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: A simulation study for individuals with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Suresh Agarwal, Cedric Hermans, Wolfgang A Miesbach, Flora Peyvandi, Robert F Sidonio, Dane Osmond, Vanessa Newman, Josh Henshaw, Steven W Pipe
Transitioning from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: A simulation study for individuals with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 30 (4) (2024)
Steven W Pipe, Peter Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial. Blood 143 (14) (2024)
Steven W Pipe, Peter Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial. Blood 143 (14) (2024)
Robbin Itzler, Tyler W Buckner, Frank W G Leebeek, Joel Miller, Michael Recht, Douglass Drelich, Paul E Monahan, Steven W Pipe
Effect of etranacogene dezaparvovec on quality of life for severe and moderately severe haemophilia B participants: Results from the phase III HOPE-B trial 2 years after gene therapy. Haemophilia : the official journal of the World Federation of Hemophilia 30 (3) (2024)
Robbin Itzler, Tyler W Buckner, Frank W G Leebeek, Joel Miller, Michael Recht, Douglass Drelich, Paul E Monahan, Steven W Pipe
Effect of etranacogene dezaparvovec on quality of life for severe and moderately severe haemophilia B participants: Results from the phase III HOPE-B trial 2 years after gene therapy. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Neeraja Swaminathan, Joshua D Smith, Hemant A Parmar, Joseph J Gemmete, Steven W Pipe, David A Zopf
Experience with trametinib in a pediatric patient with MAP2K1-related cervicofacial arteriovenous malformation. Pediatric blood & cancer (2024)
Steven W Pipe, Peter Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial. Blood 143 (14) (2024)
Steven W Pipe, Peter W Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b, open-label trial. Blood (2023)
Soracha E Ward, Thomas Guest, Ciara M Byrne, Patricia Lopes, Jamie M O'Sullivan, Dearbhla Doherty, David O'Connell, Sara Gutierrez Llaneza, Alain Chion, Judicael Fazavana, Padraic G Fallon, Roger J S Preston, Jill M Johnsen, Steven W Pipe, Peter L Turecek, James S O'Donnell, null null
Macrophage Galactose Lectin Contributes to the Regulation of FVIII (Factor VIII) Clearance in Mice. Arteriosclerosis, thrombosis, and vascular biology (2023)
Giancarlo Castaman, Michiel Coppens, Steven W Pipe
Etranacogene dezaparvovec for the treatment of adult patients with severe and moderately severe hemophilia B. Expert review of hematology (2023)
Margaret V Ragni, Guy Aaron Young, Glaivy Batsuli, Emily Bisson, Shannon L Carpenter, Stacy E Croteau, Adam Cuker, Randall G Curtis, Michael Denne, Bruce Ewenstein, Amber Federizo, Neil Frick, Kerry Funkhouser, Lindsey A George, W Keith Hoots, Shawn M Jobe, Emily Krava, Christopher James Langmead, Roger J Lewis, José López, Lynn Malec, Ziva Mann, Moses E Miles, Emma Neely, Ellis J Neufeld, Glenn F Pierce, Steven W Pipe, Lisa R Pitler, Leslie Raffini, Kathaleen M Schnur, Jordan A Shavit
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and funding. Expert review of hematology 16 (sup1) (2023)
Soracha E Ward, Thomas Guest, Ciara M Byrne, Patricia Lopes, Jamie M O'Sullivan, Dearbhla Doherty, David O'Connell, Sara Gutierrez Llaneza, Alain Chion, Judicael Fazavana, Padraic G Fallon, Roger J S Preston, Jill M Johnsen, Steven W Pipe, Peter L Turecek, James S O'Donnell, null null
Macrophage Galactose Lectin Contributes to the Regulation of FVIII (Factor VIII) Clearance in Mice. Arteriosclerosis, thrombosis, and vascular biology (2023)
Steven W Pipe, Peter W Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Victor Jimenez Yuste, Flora Peyvandi, Guy Aaron Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavakli, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin C J Fijnvandraat
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b, open-label trial. Blood (2023)
Manfred Schmidt, Graham R Foster, Michiel Coppens, Hauke Thomsen, Ricardo Dolmetsch, Liesbeth Heijink, Paul E Monahan, Steven W Pipe
Molecular Evaluation and Vector Integration Analysis of HCC Complicating AAV Gene Therapy for Hemophilia B. Blood advances (2023)
Soracha E Ward, Thomas Guest, Ciara M Byrne, Patricia Lopes, Jamie M O'Sullivan, Dearbhla Doherty, David O'Connell, Sara Gutierrez Llaneza, Alain Chion, Judicael Fazavana, Padraic G Fallon, Roger J S Preston, Jill M Johnsen, Steven W Pipe, Peter L Turecek, James S O'Donnell, null null
Macrophage Galactose Lectin Contributes to the Regulation of FVIII (Factor VIII) Clearance in Mice. Arteriosclerosis, thrombosis, and vascular biology (2023)
Steven W Pipe, Kayla Douglas, Nina Hwang, Guy Aaron Young, Priya Patel, Patrick F Fogarty
Delivery of gene therapy in haemophilia treatment centres in the United States: Practical aspects of preparedness and implementation. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Steven W Pipe, Ali Sadeghi-Khomami, Barbara A Konkle, Steve Kitchen, Claude G Negrier, Mingjie Liu, Elena Santagostino, Annemieke Willemze, Lydia Abad-Franch, Karin Knobe, Ekta Seth Chhabra
A global comparative field study to evaluate the factor VIII activity of efanesoctocog alfa by one-stage clotting and chromogenic substrate assays at clinical haemostasis laboratories. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Rebecca Kruse-Jarres, Flora Peyvandi, Johannes Oldenburg, Tiffany Chang, Sammy Chebon, Michelle Y Doral, Stacy E Croteau, Thierry Lambert, Christine L Kempton, Steven W Pipe, Richard H Ko, Benjamin Trzaskoma, Christophe Dhalluin, Nives Selak Bienz, Markus Niggli, Michaela Lehle, Ido Paz-Priel, Guy Aaron Young, Victor Jimenez Yuste
Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: experience from the HAVEN 1-4 studies. Blood advances (2022)
Steven W Pipe, Cedric Hermans, Meera Chitlur, Manuel D Carcao, Giancarlo Castaman, Joanna A Davis, Jonathan Ducore, Amy L Dunn, Miguel A Escobar, Janna Journeycake, Osman Khan, Johnny N Mahlangu, Shannon L Meeks, Ismail Haroon Mitha, Claude Négrier, Ulrike Nowak-Göttl, Michael Recht, Tammuella Chrisentery-Singleton, Oleksandra Stasyshyn, Kateryna V Vilchevska, Laura Villarreal Martinez, Michael Wang, Jerzy Windyga, Guy Aaron Young, W Allan Alexander, Daniel Bonzo, Christopher Macie, Ian S Mitchell, Evelyne Sauty, Thomas A Wilkinson, Amy D Shapiro
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors. Haemophilia : the official journal of the World Federation of Hemophilia 28 (4) (2022)
Annette von Drygalski, Esteban Gomez, Adam Giermasz, Giancarlo Castaman, Nigel S Key, Susan S Lattimore, Frank W G Leebeek, Wolfgang A Miesbach, Michael Recht, Robert Z Gut, Ricardo Dolmetsch, Paul E Monahan, Sandra Le Quellec, Steven W Pipe
Stable and durable factor IX levels in hemophilia B patients over 3 years post etranacogene dezaparvovec gene therapy. Blood advances (2022)
Steven W Pipe, K Rajender Reddy, Pratima Chowdary
Gene therapy: Practical aspects of implementation. Haemophilia : the official journal of the World Federation of Hemophilia (2022)
Steven W Pipe
Lifelong gene therapy in dogs with hemophilia A. Blood 140 (25) (2022)
Steven W Pipe
Lifelong gene therapy in dogs with hemophilia A. Blood 140 (25) (2022)
Steven W Pipe
Lifelong gene therapy in dogs with hemophilia A. Blood 140 (25) (2022)
Barbara A Konkle, Glenn F Pierce, Donna Coffin, Mayss Naccache, R Cary Clark, Lindsey A George, Alfonso Iorio, Brian O'Mahony, Steven W Pipe, Mark W Skinner, Crystal Watson, Flora Peyvandi, Johnny N Mahlangu, null null
Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH. Journal of thrombosis and haemostasis : JTH 18 (11) (2021)
Charles R M Hay, Francis Nissen, Steven W Pipe
Mortality in congenital hemophilia A - a systematic literature review. Journal of thrombosis and haemostasis : JTH (2021)
Steven W Pipe, Rebecca Kruse-Jarres, Johnny N Mahlangu, Glenn F Pierce, Flora Peyvandi, Peter Kuebler, Christian De Ford, Fabián Sanabria, Richard H Ko, Tiffany Chang, Charles R M Hay
Establishment of a framework for assessing mortality in persons with congenital hemophilia A and its application to an adverse event reporting database. Journal of thrombosis and haemostasis : JTH (2021)
Flora Peyvandi, Johnny N Mahlangu, Steven W Pipe, Charles R M Hay, Glenn F Pierce, Peter Kuebler, Rebecca Kruse-Jarres, Midori Shima
Application of a hemophilia mortality framework to the Emicizumab Global Safety Database. Journal of thrombosis and haemostasis : JTH (2021)
Barbara A Konkle, Steven W Pipe
Diagnosis and management of von Willebrand disease: A community-wide effort to deliver evidence-based clinical practice guidelines. Haemophilia : the official journal of the World Federation of Hemophilia 27 (2) (2021)
Imi Faghmous, Francis Nissen, Peter Kuebler, Carlos Flores Avile, Anisha M Patel, Steven W Pipe
Estimating the risk of thrombotic events in people with congenital hemophilia A using US claims data. Journal of comparative effectiveness research 10 (18) (2021)
Mark W Skinner, Claude G Negrier, Ido Paz-Priel, Sammy Chebon, Victor Jimenez Yuste, Michael U Callaghan, Michaela Lehle, Markus Niggli, Johnny N Mahlangu, Amy D Shapiro, Midori Shima, Avrita Campinha-Bacote, Gallia G Levy, Johannes Oldenburg, Sylvia von Mackensen, Steven W Pipe
The effect of emicizumab prophylaxis on long-term, self-reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies. Haemophilia : the official journal of the World Federation of Hemophilia 27 (5) (2021)
Radoslaw Kaczmarek, Magdy El Ekiaby, Daniel P Hart, Cedric Hermans, Michael P Makris, Declan Noone, Brian William O'Mahony, David Page, Flora Peyvandi, Steven W Pipe, Thomas Sannié, Uwe Schlenkrich, Mark W Skinner, Alok Srivastava, Amanda Bok, Glenn F Pierce, null null
Vaccination against COVID-19: Rationale, modalities and precautions for patients with haemophilia and other inherited bleeding disorders. Haemophilia : the official journal of the World Federation of Hemophilia 27 (4) (2021)
Andrew Yee, Manhong Dai, Stacy E Croteau, Jordan A Shavit, Steven W Pipe, David Siemieniak, Fan Meng, David Ginsburg
Phage display broadly identifies inhibitor-reactive regions in von Willebrand factor. Journal of thrombosis and haemostasis : JTH 19 (11) (2021)
Aric D Parnes, Johnny N Mahlangu, Steven W Pipe, Ido Paz-Priel, Michaela Lehle, Peter C Trask, Victor Jimenez Yuste
Patient preference for emicizumab versus prior factor therapy in people with haemophilia A: Results from the HAVEN 3 and HAVEN 4 studies. Haemophilia : the official journal of the World Federation of Hemophilia 27 (6) (2021)
Wolfgang Miesbach, K John Pasi, Steven W Pipe, Cedric Hermans, Brian O'Mahony, Christine J Guelcher, Bruno Steiner, Mark W Skinner
Evolution of haemophilia integrated care in the era of gene therapy: Treatment centre's readiness in United States and EU. Haemophilia : the official journal of the World Federation of Hemophilia 27 (4) (2021)
Leonard A Valentino, Mark W Skinner, Steven W Pipe
The role of telemedicine in the delivery of health care in the COVID-19 pandemic. Haemophilia : the official journal of the World Federation of Hemophilia 26 (5) (2020)
Alok Srivastava, Elena Santagostino, Alison Dougall, Steve Kitchen, Megan Sutherland, Steven W Pipe, Manuel D Carcao, Johnny N Mahlangu, Margaret V Ragni, Jerzy Windyga, Adolfo Llinás, Nicholas J Goddard, Richa Mohan, Pradeep Mathew Poonnoose, Brian M Feldman, Sandra Zelman Lewis, H Marijke van den Berg, Glenn F Pierce, null null
WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia : the official journal of the World Federation of Hemophilia (2020)
Manuel D Carcao, Amy D Shapiro, Nina Hwang, Steven W Pipe, Sanjay Ahuja, Ken Lieuw, Janice M Staber, Mark Belletrutti, Haowei Linda Sun, Hilda Ding, Michael Wang, Victoria Price, MacGregor Steele, Elisa Tsao, Jing Feng, Zahra Al-Khateeb, Jennifer Dumont, Nisha Jain
Real-world data of immune tolerance induction using recombinant factor VIII Fc fusion protein in patients with severe haemophilia A with inhibitors at high risk for immune tolerance induction failure: A follow-up retrospective analysis. Haemophilia : the official journal of the World Federation of Hemophilia 27 (1) (2020)
Flora Peyvandi, David Lillicrap, Johnny Mahlangu, Claire McLintock, K John Pasi, Steven W Pipe, Wendy Scales, Alok Srivastava, Thierry VandenDriessche
Hemophilia gene therapy knowledge and perceptions: Results of an international survey. Research and practice in thrombosis and haemostasis 4 (4) (2020)
Steven W Pipe, Radoslaw Kaczmarek, Alok Srivastava, Glenn F Pierce, Michael P Makris, Cedric Hermans, null null, null null
Management of COVID-19-associated coagulopathy in persons with haemophilia. Haemophilia : the official journal of the World Federation of Hemophilia 27 (1) (2020)
Peter L Turecek, Jill M Johnsen, Steven W Pipe, James S O'Donnell, null null
Biological mechanisms underlying inter-individual variation in factor VIII clearance in haemophilia. Haemophilia : the official journal of the World Federation of Hemophilia 26 (4) (2020)
Morgan Stuart, Linda Johnson, Sarah Hanigan, Steven W Pipe, Shih-Hon Li
Anti-factor IIa (FIIa) heparin assay for patients on direct factor Xa (FXa) inhibitors. Journal of thrombosis and haemostasis : JTH 18 (7) (2020)
Steven W Pipe
Delivering on the promise of gene therapy for haemophilia. Haemophilia : the official journal of the World Federation of Hemophilia (2020)
Angela Christine Weyand, Veronica H Flood, Jordan A Shavit, Steven W Pipe
Efficacy of emicizumab in a pediatric patient with type 3 von Willebrand disease and alloantibodies. Blood advances 3 (18) (2020)
Steven W Pipe, Denise E Sabatino, Diane J Nugent, W Craig Hooper, J Michael Soucie, W Keith Hoots, Donna M DiMichele
Executive summary of the NHLBI State of the Science (SOS) Workshop: Overview and next steps in generating a national blueprint for future research on factor VIII inhibitors. Haemophilia : the official journal of the World Federation of Hemophilia 25 (4) (2020)
Steven W Pipe
New treatment paradigm for hemophilia poses challenges for legacy bioassays. Journal of thrombosis and haemostasis : JTH 17 (9) (2020)
Angela Christine Weyand, Adam L Dorfman, Jordan A Shavit, Steven W Pipe
Emicizumab prophylaxis to facilitate anticoagulant therapy for management of intra-atrial thrombosis in severe haemophilia with an inhibitor. Haemophilia : the official journal of the World Federation of Hemophilia 25 (3) (2019)
Steven W Pipe, Sundar R Selvaraj
Gene editing in hemophilia: a "CRISPR" choice? Blood 133 (26) (2019)
Denise E Sabatino, Steven W Pipe, Diane J Nugent, J Michael Soucie, W Craig Hooper, W Keith Hoots, Donna M DiMichele
Origins and organization of the NHLBI State of the Science Workshop: Generating a national blueprint for future research on factor VIII inhibitors. Haemophilia : the official journal of the World Federation of Hemophilia 25 (4) (2019)
Courtney Dawn Thornburg, Robert R Montgomery, Steven W Pipe
How we approach: Training pediatric coagulationists. Pediatric blood & cancer 66 (12) (2019)
Angela Christine Weyand, Steven W Pipe
New therapies for hemophilia. Blood 133 (5) (2018)
Michael U Callaghan, Robert F Sidonio, Steven W Pipe
Novel therapeutics for hemophilia and other bleeding disorders. Blood 132 (1) (2018)
Steven W Pipe
Gene therapy for hemophilia. Pediatric blood & cancer 65 (2) (2017)